Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2025-12-26 @ 1:30 AM
NCT ID: NCT00397033
Description: Safety Population
Frequency Threshold: 5
Time Frame: None
Study: NCT00397033
Study Brief: Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo None None None 6 107 61 107 View
Paliperidone Extended Release (ER) High Dose Paliperidone Extended Release (ER) High Dose - 12mg/day with option to reduce to 9mg/day None None 2 98 68 98 View
Paliperidone Extended Release (ER) Low Dose Paliperidone Extended Release (ER) Low Dose - 6mg/day with option to reduce to 3mg/day None None 10 108 78 108 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Supraventricular tachycardia SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 9.0 View
Salpingitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Urinary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Uterine leiomyoma SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA 9.0 View
Grand mal convulsion SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Depressed mood SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Depression SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Psychotic disorder SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Schizoaffective disorder SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Suicidal behavior SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Suicidal ideation SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Metrorrhagia SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA 9.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Dry Mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Akathisia SYSTEMATIC_ASSESSMENT Nervous system disorders 9.0 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders 9.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders 9.0 View
Hypertonia SYSTEMATIC_ASSESSMENT Nervous system disorders 9.0 View
Sedation SYSTEMATIC_ASSESSMENT Nervous system disorders 9.0 View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders 9.0 View
Tremor SYSTEMATIC_ASSESSMENT Nervous system disorders 9.0 View
Agitation SYSTEMATIC_ASSESSMENT Psychiatric disorders 9.0 View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders 9.0 View
Schizoaffective Disorder SYSTEMATIC_ASSESSMENT Psychiatric disorders 9.0 View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View